Thailand HIV/AIDS and infectious disease clinical trials unit

The Thai Red Cross AIDS Research Centre (TRCARC) HIV Treatment Clinical Research Site operates under the…

Gut microbiome and NASH in HIV

Description: n/a

Implementation for tuberculosis preventive therapy among latent tuberculosis infection in HIV-infected individuals using novel regimen of Isoniazid/Rifapentine daily (4 weeks) compared to Isoniazid/Rifapentine weekly (12 weeks)

This study is a multicenter, randomized, open-label, phase III clinical trial of INH/RPT (Isoniazid/Rifapentine) regimen administered…

Bictegravir/TAF/FTC in HIV/HBV co-infection

Description: n/a

Human papillomavirus infection in perinatally HIV-infected adolescents in Asia

This is a longitudinal case-control study to monitor a cohort of perinatally HIV-infected and matched HIV–uninfected…

Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase III clinical trial

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis…

BioBank for Surrogate Marker Research for TB (B-SMART)

This protocol serves two purposes: To collect and store relevant biological specimens for repository biobanking to…

Efficacy and liver fibrosis improvement in compensated cirrhotic patients with chronic HCV genotypes 1 and 6 infection with and without HIV co-infection receiving the combination regimen of Grazoprevir and Elbasvir

This study will evaluate the safety and efficacy of combination treatment with grazoprevir + elbasvir for…

Liver disease progression in HIV/HBV co-infection SOFIA: cross-sectional cohort

This is a cross-sectional, international multi-site cohort study to investigate the relationship between changes on liver…

Cross-sectional study examining the prevalence rate and determinants of frailty in the HIV positive and negative Thai populations

This is a cross-sectional study examining the prevalence rate and determinants of frailty in the HIV…